Clinical applications of mesenchymal stem cells

다국어 초록 (Multilingual Abstract)

Mesenchymal stem cells (MSCs) are self-renewing, multipotent progenitor cells with multilineage potential to differentiate into cell types of mesodermal origin,such as adipocytes, osteocytes, and chondrocytes. In addition, MSCs can migrate to sites of inflammation and exert potent immunosuppressive and anti-inflammatory effects through interactions between lymphocytes associated with both the innate and adaptive immune system. Along with these unique therapeutic properties, their ease of accessibility and expansion suggest that use of MSCs may be a useful therapeutic approach for various disorders. In the clinical setting,MSCs are being explored in trials of various conditions, including orthopedic injuries,graft versus host disease following bone marrow transplantation, cardiovascular diseases, autoimmune diseases, and liver diseases. Furthermore, genetic modification of MSCs to overexpress antitumor genes has provided prospects for clinical use as anticancer therapy. Here, we highlight the currently reported uses of MSCs in clinical trials and discuss their efficacy as well as their limitations.

참고문헌 (Reference)

1 Ball SG, "Vascular endothelial growth factor can signal through platelet-derived growth factor receptors" 177 : 489-500, 2007

2 Sun L, "Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus" 62 : 2467-2475, 2010

3 Fang B, "Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells" 38 : 389-390, 2006

4 Le Blanc K, "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells" 363 : 1439-1441, 2004

5 von Bonin M, "Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium" 43 : 245-251, 2009

6 Gonzalez MA, "Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells" 60 : 1006-1019, 2009

7 Kuroda R, "Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells" 15 : 226-231, 2007

8 Nagaya N, "Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy" 112 : 1128-1135, 2005

9 Macmillan ML, "Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial" 43 : 447-454, 2009

10 Horwitz EM, "Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta" 5 : 309-313, 1999

11 Park MJ, "Transforming growth factor beta-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis" 63 : 1668-1680, 2011

12 Katritsis DG, "Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium" 65 : 321-329, 2005

13 Wang H, "Traff icking mesenchymal stem cell engraftment and differentiation in tumor- bearing mice by bioluminescence imaging" 27 : 1548-1558, 2009

14 Ren C, "Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model" 26 : 2332-2338, 2008

15 Gao P, "Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma" 290 : 157-166, 2010

16 Seok-Goo Cho, "The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation" 생화학분자생물학회 45 (45): 1-10, 2013

17 Marigo I, "The immunomodulatory properties of mesenchymal stem cells" 33 : 593-602, 2011

18 Seo SH, "The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity" 18 : 488-495, 2011

19 Ning H, "The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study" 22 : 593-599, 2008

20 Kanehira M, "Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells" 14 : 894-903, 2007

21 Xin H, "Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells" 25 : 1618-1626, 2007

22 Mueller LP, "TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo" 18 : 229-239, 2011

23 Qiao L, "Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model" 18 : 500-507, 2008

24 Jiang S, "Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair" 99 : 776-784, 2006

25 Tolar J, "Sarcoma derived from cultured mesenchymal stem cells" 25 : 371-379, 2007

26 Karussis D, "Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis" 67 : 1187-1194, 2010

27 Krampera M, "Role for interferon- gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells" 24 : 386-398, 2006

28 Wakitani S, "Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees" 1 : 74-79, 2007

29 Banfi A, "Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy" 28 : 707-715, 2000

30 Rombouts WJ, "Primary murine MSC show highly eff icient homing to the bone marrow but lose homing ability following culture" 17 : 160-170, 2003

31 Jiang Y, "Pluripotency of mesenchymal stem cells derived from adult marrow" 418 : 41-49, 2002

32 Lucchini G, "Platelet-lysate- expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population" 16 : 1293-1301, 2010

33 Ichim TE, "Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy" 16 : 898-905, 2008

34 Mohamadnejad M, "Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis" 10 : 459-466, 2007

35 Katritsis DG, "Papamichail M. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells" 9 : 167-171, 2007

36 Wang Y, "Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture" 7 : 509-519, 2005

37 Riordan NH, "Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis" 7 : 29-, 2009

38 Kuzmina LA, "Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease: a phase II study" 2012 : 968213-, 2012

39 Schwartz RE, "Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells" 109 : 1291-1302, 2002

40 Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells" 284 : 143-147, 1999

41 Zuk PA, "Multilineage cells from human adipose tissue: implications for cell-based therapies" 7 : 211-228, 2001

42 Dwyer RM, "Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells" 13 : 5020-5027, 2007

43 Roubelakis MG, "Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells" 16 : 931-952, 2007

44 Dominici M, "Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement" 8 : 315-317, 2006

45 Satake K, "Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue" 29 : 1971-1979, 2004

46 Son BR, "Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases" 24 : 1254-1264, 2006

47 Tremain N, "MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages" 19 : 408-418, 2001

48 Joo SY, "Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner" 12 : 361-370, 2010

49 Karnoub AE, "Mesenchymal stem cells within tumour stroma promote breast cancer metastasis" 449 : 557-563, 2007

50 Ip JE, "Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment" 18 : 2873-2882, 2007

51 Patel SA, "Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta" 184 : 5885-5894, 2010

52 Madec AM, "Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells" 52 : 1391-1399, 2009

53 Spaggiari GM, "Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2" 111 : 1327-1333, 2008

54 Nauta AJ, "Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells" 177 : 2080-2087, 2006

55 Ramasamy R, "Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle" 83 : 71-76, 2007

56 Ringden O, "Mesenchymal stem cells for treatment of therapy-resistant graftversus- host disease" 81 : 1390-1397, 2006

57 Le Blanc K, "Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study" 371 : 1579-1586, 2008

58 Dazzi F, "Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells" 38 : 1479-1482, 2008

59 Sonabend AM, "Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma" 26 : 831-841, 2008

60 Zhu W, "Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo" 80 : 267-274, 2006

61 Stoff-Khalili MA, "Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma" 105 : 157-167, 2007

62 Zappia E, "Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy" 105 : 1755-1761, 2005

63 Ren G, "Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide" 2 : 141-150, 2008

64 Choi YS, "Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect" 41 : 214-229, 2012

65 Liang J, "Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE" 6 : 486-489, 2010

66 Loebinger MR, "Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer" 69 : 4134-4142, 2009

67 Weng JY, "Mesenchymal stem cell as salvage treatment for refractory chronic GVHD" 45 : 1732-1740, 2010

68 Erices A, "Mesenchymal progenitor cells in human umbilical cord blood" 109 : 235-242, 2000

69 Komarova S, "Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses" 5 : 755-766, 2006

70 Di Ianni M, "Mesenchymal cells recruit and regulate T regulatory cells" 36 : 309-318, 2008

71 Stagg J, "Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy" 15 : 597-608, 2004

72 Whyte MP, "Marrow cell transplantation for infantile hypophosphatasia" 18 : 624-636, 2003

73 Horwitz EM, "Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone" 99 : 8932-8937, 2002

74 Gunnarsson S, "Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma" 218 : 140-144, 2010

75 Chen S, "Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery" 18 : 552-556, 2006

76 Zeinaloo A, "Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy" 15 : 183-186, 2011

77 Stagg J, "Interferon- gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell" 107 : 2570-2577, 2006

78 Maccario R, "Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/ suppressive phenotype" 90 : 516-525, 2005

79 Cahill RA, "Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts" 92 : 2923-2930, 2007

80 Anjos-Afonso F, "In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions" 117 : 5655-5664, 2004

81 Kharaziha P, "Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial" 21 : 1199-1205, 2009

82 Ye Z, "Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells" 7 : 608-614, 2008

83 Mao F, "Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis" 59 : 219-225, 2010

84 Djouad F, "Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals" 102 : 3837-3844, 2003

85 van Eekelen M, "Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors" 29 : 3185-3195, 2010

86 Zhang Y, "Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells" 32 : 657-664, 2004

87 Groh ME, "Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells" 33 : 928-934, 2005

88 Aggarwal S, "Human mesenchymal stem cells modulate allogeneic immune cell responses" 105 : 1815-1822, 2005

89 Corcione A, "Human mesenchymal stem cells modulate B-cell functions" 107 : 367-372, 2006

90 Jiang XX, "Human mesenchymal stem cells inhibit differentiation and function of monocyte- derived dendritic cells" 105 : 4120-4126, 2005

91 Khakoo AY, "Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma" 203 : 1235-1247, 2006

92 Toma C, "Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart" 105 : 93-98, 2002

93 Beyth S, "Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness" 105 : 2214-2219, 2005

94 Nakamizo A, "Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas" 65 : 3307-3318, 2005

95 Yong RL, "Human bone marrow- derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas" 69 : 8932-8940, 2009

96 Di Nicola M, "Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli" 99 : 3838-3843, 2002

97 Meisel R, "Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase- mediated tryptophan degradation" 103 : 4619-4621, 2004

98 Wakitani S, "Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees" 10 : 199-206, 2002

99 Keating A., "How do mesenchymal stromal cells suppress T cells?" 2 : 106-108, 2008

100 Palumbo R, "High mobility group box 1 protein, a cue for stem cell recruitment" 68 : 1165-1170, 2004

101 Forte G, "Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation" 24 : 23-33, 2006

102 Tropel P, "Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells" 24 : 2868-2876, 2006

103 Pijnappels DA, "Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures" 103 : 167-176, 2008

104 Chen B, "Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6" 159 : 292-302, 2010

105 Le Blanc K, "Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta" 79 : 1607-1614, 2005

106 Garcia-Olmo D, "Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial" 52 : 79-86, 2009

107 Zhou H, "Efficacy of bone marrow- derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report" 16 : 403-412, 2010

108 Prasad VK, "Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study" 17 : 534-541, 2011

109 Zhang W, "Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells" 13 : 263-271, 2004

110 Wu KH, "Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells" 91 : 1412-1416, 2011

111 Chen SL, "Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction" 94 : 92-95, 2004

112 Mohyeddin Bonab M, "Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study" 4 : 50-57, 2007

113 Rose RA, "Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes?" 103 : 120-, 2008

114 Schurgers E, "Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis" 12 : 31-, 2010

115 Pereira RF, "Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice" 92 : 4857-4861, 1995

116 Bieback K, "Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood" 22 : 625-634, 2004

117 Baron F, "Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning" 16 : 838-847, 2010

118 Ball LM, "Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation" 10 : 2764-2767, 2007

119 Lazarus HM, "Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients" 11 : 389-398, 2005

120 Otsu K, "Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells" 113 : 4197-4205, 2009

121 Zhang S, "Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source" 99 : 1132-1147, 2006

122 Bernardo ME, "Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation" 46 : 200-207, 2011

123 Horwitz EM, "Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta" 97 : 1227-1231, 2001

124 Palumbo R, "Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation" 179 : 33-40, 2007

125 English K, "Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25( High) forkhead box P3+ regulatory T cells" 156 : 149-160, 2009

126 Ren C, "Cancer gene therapy using mesenchymal stem cells expressing interferon- beta in a mouse prostate cancer lung metastasis model" 15 : 1446-1453, 2008

127 Balkwill F., "Cancer and the chemokine network" 4 : 540-550, 2004

128 Miletic H, "Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene" 15 : 1373-1381, 2007

129 Bae JS, "Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration" 25 : 1307-1316, 2007

130 Studeny M, "Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors" 62 : 3603-3608, 2002

131 Cogle CR, "Bone marrow transdifferentiation in brain after transplantation: a retrospective study" 363 : 1432-1437, 2004

132 Nemeth K, "Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma" 107 : 5652-5657, 2010

133 Glennie S, "Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells" 105 : 2821-2827, 2005

134 Yamout B, "Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study" 227 : 185-189, 2010

135 Augello A, "Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway" 35 : 1482-1490, 2005

136 Petersen BE, "Bone marrow as a potential source of hepatic oval cells" 284 : 1168-1170, 1999

137 Izadpanah R, "Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue" 99 : 1285-1297, 2006

138 Fiedler J, "BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells" 87 : 305-312, 2002

139 Carrion F, "Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients" 19 : 317-322, 2010

140 Wakitani S, "Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports" 13 : 595-600, 2004

141 Muller I, "Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation" 40 : 25-32, 2008

142 Tyndall A., "Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases" 71 (71): 433-438, 2012

143 Ramos CA, "An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies" 28 : 1107-1115, 2010

144 Winner M, "Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization" 67 : 186-193, 2007

145 Liang J, "Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study" 69 : 1423-1429, 2010

146 Dai W, "Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects" 112 : 214-223, 2005

147 Zheng ZH, "Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis" 47 : 22-30, 2008

148 Tabbara IA, "Allogeneic hematopoietic stem cell transplantation: complications and results" 162 : 1558-1566, 2002

149 Kebriaei P, "Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease" 15 : 804-811, 2009

150 Cavarretta IT, "Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth" 18 : 223-231, 2010

151 Sun LY, "Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus" 16 : 121-128, 2007

152 Hare JM, "A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction" 54 : 2277-2286, 2009

153 Garcia-Olmo D, "A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation" 48 : 1416-1423, 2005

154 Yang Z, "A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery" 28 : 380-385, 2010